Literature DB >> 18692048

Suppression of hepatitis C virus replication by baculovirus vector-mediated short-hairpin RNA expression.

Hitoshi Suzuki1, Nobushige Tamai, Yuichiro Habu, Myint O O Chang, Hiroshi Takaku.   

Abstract

Short-hairpin RNAs (shRNAs) inhibit gene expression by RNA interference. Here, we report on the inhibition, by baculovirus-based vector-derived shRNAs, of core-protein expression in full-length hepatitis C virus (HCV) replicon cells. shRNAs were designed to target the highly conserved core region of the HCV genome. In particular, the core-shRNA452 containing nucleotides 452-472, as the target in the HCV core gene, dramatically inhibited the expression of the HCV core protein in replicon cells. Furthermore, HCV core-protein expression was inhibited more strongly by the vesicular stomatitis virus glycoprotein (VSV-G)-pseudotyped baculovirus vector than by the wild-type baculovirus vector.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692048     DOI: 10.1016/j.febslet.2008.07.056

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis.

Authors:  Chiu-Ling Chen; Jaw-Ching Wu; Guan-Yu Chen; Pei-Hsiang Yuan; Yen-Wen Tseng; Kuei-Chang Li; Shiaw-Min Hwang; Yu-Chen Hu
Journal:  Mol Ther       Date:  2014-07-15       Impact factor: 11.454

Review 2.  New short interfering RNA-based therapies for glomerulonephritis.

Authors:  Hideki Shimizu; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

3.  In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.

Authors:  Helen Lavender; Kevin Brady; Frances Burden; Oona Delpuech-Adams; Hubert Denise; Amy Palmer; Hannah Perkins; Boris Savic; Sarah Scott; Caroline Smith-Burchnell; Phil Troke; J Fraser Wright; David Suhy; Romu Corbau
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

Review 4.  Selective gene silencing by viral delivery of short hairpin RNA.

Authors:  Katja Sliva; Barbara S Schnierle
Journal:  Virol J       Date:  2010-09-21       Impact factor: 4.099

5.  Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs.

Authors:  Saba Khaliq; Shah Jahan; Bushra Ijaz; Waqar Ahmad; Sultan Asad; Asim Pervaiz; Baila Samreen; Mahwish Khan; Sajida Hassan
Journal:  Virol J       Date:  2010-11-13       Impact factor: 4.099

6.  Bioluminescence imaging allows monitoring hepatitis C virus core protein inhibitors in mice.

Authors:  Juan Du; Fang Zhao; Yong Zhou; Hu Yan; Xiang-guo Duan; Sheng-qiang Liang; Ying-li Wang; Qiu-xia Fu; Xiao-hui Wang; Jian-chun Peng; Lin-sheng Zhan
Journal:  PLoS One       Date:  2010-11-18       Impact factor: 3.240

Review 7.  Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications.

Authors:  Chi-Yuan Chen; Chin-Yu Lin; Guan-Yu Chen; Yu-Chen Hu
Journal:  Biotechnol Adv       Date:  2011-04-28       Impact factor: 14.227

8.  Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy.

Authors:  Hitoshi Suzuki; Norihiko Matsumoto; Tomoyuki Suzuki; Myint Oo Chang; Hiroshi Takaku
Journal:  Virol J       Date:  2009-10-02       Impact factor: 4.099

Review 9.  Baculovirus-mediated gene delivery and RNAi applications.

Authors:  Kaisa-Emilia Makkonen; Kari Airenne; Seppo Ylä-Herttulala
Journal:  Viruses       Date:  2015-04-22       Impact factor: 5.048

10.  Special Issue: Gene Therapy with Emphasis on RNA Interference.

Authors:  Kenneth Lundstrom
Journal:  Viruses       Date:  2015-08       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.